Remarkable, these results are very similar to those found with 5-aza-CdR in a breast cancer model of MASPIN re-expression where reductions in G9A histone methyltransferase protein levels are not due to effects on G9A gene expression [53]. The gene discussed is EHMT2; the disease is breast carcinoma.